<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00304980</url>
  </required_header>
  <id_info>
    <org_study_id>02 52 5 406</org_study_id>
    <nct_id>NCT00304980</nct_id>
  </id_info>
  <brief_title>Comparative Evaluation of the Safety and the Efficacy of 2 Antimalarials Depending on HIV Status</brief_title>
  <official_title>Comparative Evaluation of the Safety and the Efficacy of Artemether + Lumefantrine (Coartem™) vs. Sulfadoxine + Pyrimethamine (SP) in Both HIV+ and HIV- Adults With Uncomplicated P. Falciparum Malaria in Zambia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institute of Tropical Medicine, Belgium</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institute of Tropical Medicine, Belgium</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the safety and efficacy of
      sulfadoxine-pyrimethamine (SP) versus artemether-lumefantrine (Coartem) when administered to
      HIV+ and HIV- patients with uncomplicated P. falciparum malaria. Patients will be randomised
      to one of the 2 treatment and followed up (until day 14 actively) for 45 days.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <start_date>March 2003</start_date>
  <completion_date>April 2005</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>PCR corrected clinical and parasitological outcome at day 45</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Tolerability</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical recovery</measure>
  </secondary_outcome>
  <enrollment>3000</enrollment>
  <condition>Plasmodium Falciparum Malaria</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ARTEMETHER + LUMEFANTRINE VS. SULFADOXINE + PYRIMETHAMINE</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Man and non-pregnant women aged between 15 and 50.

          -  P.falciparum mono-infection of at least 1,000 parasites/µl.

          -  Body temperature ≥ 37.5°C at the moment of enrolment or history of fever in the
             preceding 48 hrs.

          -  Consent from patient obtained.

        Exclusion Criteria:

          -  Pregnancy.

          -  Severe P. falciparum malaria .

          -  Documented intake of SP or Coartem two weeks or less prior recruitment.

          -  Other cause(s) of fever.

          -  Evidence of underlying chronic diseases (cardiac, renal, hepatic, malnutrition).

          -  History of allergy to study drug, or known allergy to other Sulphur drugs such as
             co-trimoxazol.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Umberto D'Alessandro, MD,MSc, PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute of Tropical Medicine, Antwerp</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tropical Disease Research Center</name>
      <address>
        <city>Ndola</city>
        <state>Cupperbelt</state>
        <country>Zambia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Zambia</country>
  </location_countries>
  <results_reference>
    <citation>Van Geertruyden JP, Mulenga M, Mwananyanda L, Chalwe V, Moerman F, Chilengi R, Kasongo W, Van Overmeir C, Dujardin JC, Colebunders R, Kestens L, D'Alessandro U. HIV-1 immune suppression and antimalarial treatment outcome in Zambian adults with uncomplicated malaria. J Infect Dis. 2006 Oct 1;194(7):917-25. Epub 2006 Aug 29.</citation>
    <PMID>16960779</PMID>
  </results_reference>
  <verification_date>September 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 20, 2006</study_first_submitted>
  <study_first_submitted_qc>March 20, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 21, 2006</study_first_posted>
  <last_update_submitted>September 12, 2010</last_update_submitted>
  <last_update_submitted_qc>September 12, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 14, 2010</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Malaria</mesh_term>
    <mesh_term>Malaria, Falciparum</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lumefantrine</mesh_term>
    <mesh_term>Artemether</mesh_term>
    <mesh_term>Pyrimethamine</mesh_term>
    <mesh_term>Sulfadoxine</mesh_term>
    <mesh_term>Artemether-lumefantrine combination</mesh_term>
    <mesh_term>Artemisinins</mesh_term>
    <mesh_term>Fanasil, pyrimethamine drug combination</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

